Other

Valeant to buy Bausch + Lomb for $8.7B (Update)

Canadian drugmaker Valeant Pharmaceuticals said Monday that it will pay $8.7 billion to buy Bausch + Lomb, one of the world's best-known makers of contact lenses, in a massive expansion of Valeant's smaller ophthalmology ...

Medications

US pharmaceutical firm Moderna to build plant in Africa

US pharmaceutical giant Moderna announced Thursday it would build a plant in Africa, as pressure mounts on drugmakers to help ramp up COVID-19 vaccine production in areas that have received fewer doses.

Medications

Pharma firms turn attention to hearing loss

Hearing loss affects 36 million Americans to some degree, often leaving them feeling isolated, but it has received little attention from the pharmaceutical industry—until now. Small firms have brought a handful of potential ...

page 3 from 3